Cargando…
Congenital heart disease does not entail an increased risk for severe COVID‐19
AIM: To analyse the risk of developing serious disease or death due to COVID‐19 among patients who underwent heart surgery during childhood. METHODS: A retrospective combined register and patient file study. We identified all individuals who had undergone surgery for congenital heart disease in chil...
Autores principales: | Ekman‐Joelsson, Britt‐Marie, Sunnegårdh, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877555/ https://www.ncbi.nlm.nih.gov/pubmed/36330671 http://dx.doi.org/10.1111/apa.16588 |
Ejemplares similares
-
Congenital heart disease and risk of severe COVID
por: Lim, Gregory B.
Publicado: (2021) -
Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39 821 newborns
por: de-Wahl Granelli, Anne, et al.
Publicado: (2009) -
Parent’s experiences of counselling and their need for support following a prenatal diagnosis of congenital heart disease - a qualitative study in a Swedish context
por: Bratt, Ewa-Lena, et al.
Publicado: (2015) -
Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013) -
Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms
por: Hamberg, Anna-Karin, et al.
Publicado: (2013)